You are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry.
Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Enter a Company name above to access free BCIQ profiles. Request a trial to unlock the full value of BCIQ.
Serometrix LLC
Headquarters:Pittsford, NY
Year Founded:2004
Status:Archived
Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules*.*desktop version only

BioCentury | Apr 23, 2021

Management Tracks

Genfit unveils a new CFO; plus Evotec, Autolus, Celyad, Lumos, Dewpoint and more

...for fibrotic and autoimmune diseases, hired Jonathan Bourne as CSO. Bourne was director of biophysics at Serometrix LLC.Proteomics...

BioCentury | Jan 14, 2021

Deals

Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more

...program through Serometrix dealEsperion Therapeutics Inc. (NASDAQ:ESPR) in-licensed a preclinical oral PCSK9 inhibitor program from Serometrix LLC...

BioCentury | Apr 20, 2017

Product R&D

Stalling translation

...but was shut down the next year when the company failed to find suitable molecules. Serometrix LLC...
...Ribometrix Inc., Chapel Hill, N.C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...

BioCentury | Oct 05, 2015

Emerging Company Profile

Picking a PCSK9

...and antagonists of the PCSK9/LDL receptor interaction and plans to begin IND-enabling studies next year. Serometrix LLC...
...Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...

BioCentury | Sep 21, 2015

Product Development

Alnylam's lipid sync

...approaches to inhibiting PCSK9. Pfizer Inc. , Liphorus Pharmaceuticals Inc. , Shifa Biomedical Corp. and Serometrix LLC...
...NYSE:PFE), New York, N.Y. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...

BioCentury | Feb 06, 2014

Targets & Mechanisms

PCSK9 peptide inhibitors

...However, these compounds all require parenteral administration, and orally available inhibitors still lag far behind. Serometrix LLC...
...and Shifa Biomedical Corp. have disclosed preclinical small molecule programs for oral inhibitors of PCSK9. Serometrix...
...and AMP-activated protein kinase ( AMPK ) activator, in Phase IIb testing to treat hypercholesterolemia. Serometrix...

BioCentury | Apr 30, 2012

Product Development

Beyond statins: LDL diversity

...oligonucleotide SC Preclin Shifa Biomedical Corp. NA Small molecule Oral Preclin (preclin POC by YE12) Serometrix LLC...

BioCentury | Apr 30, 2012

Product Development

PCSK9 bandwagon

...the Holy Grail is always going to be an orally active small molecule," she said. Serometrix LLC...
...Inc. , Richmond Va. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Serometrix LLC...